CB · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $59.40B | $55.75B | $49.73B | $43.10B | $40.87B | $35.99B | $34.19B | $32.72B |
| Selling, General & Administrative | $4.50B | $4.38B | $4.01B | $3.40B | $3.13B | $2.98B | $3.03B | $2.89B |
| Interest Expense | $764.00M | $741.00M | $672.00M | $570.00M | $492.00M | $516.00M | $552.00M | $641.00M |
| Other Income / (Expense) | $1.30B | $1.02B | $836.00M | -$89.00M | $2.37B | $994.00M | $596.00M | $434.00M |
| Income Before Taxes | $13.04B | $11.46B | $9.53B | $6.49B | $9.79B | $4.16B | $5.25B | $4.66B |
| Provision for Income Taxes | $2.42B | $1.81B | $511.00M | $1.24B | $1.27B | $629.00M | $795.00M | $695.00M |
| Net Income | $10.31B | $9.27B | $9.03B | $5.25B | $8.53B | $3.53B | $4.45B | $3.96B |
| Basic EPS | $25.93 | $22.94 | $21.97 | $12.50 | $19.38 | $7.82 | $9.77 | $8.55 |
| Diluted EPS | $25.68 | $22.70 | $21.80 | $12.39 | $19.24 | $7.79 | $9.71 | $8.49 |
| Basic Shares Outstanding | 397.61M | 404.19M | 410.85M | 419.78M | 439.97M | 451.60M | 455.91M | 463.63M |
| Diluted Shares Outstanding | 401.51M | 408.49M | 414.20M | 423.53M | 443.20M | 453.44M | 458.91M | 466.80M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $27.45 | $25.99 | $29.39 | 15 | ↑14 ↓0 |
| Dec 2027 | $28.74 | $25.85 | $31.21 | 14 | ↑4 ↓6 |
| Dec 2028 | $31.25 | $29.98 | $33.52 | 7 | ↑3 ↓0 |
| Dec 2029 | $26.99 | $26.99 | $26.99 | 1 | ↑1 ↓0 |